4.7 Article

Impact of the COVID-19 pandemic on access to healthcare services amongst patients with multiple sclerosis in the Lazio region, Italy

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Multiple sclerosis and COVID-19: how many are at risk?

G. Bsteh et al.

Summary: This study aimed to determine the frequency and distribution of COVID-19 mortality risk factors in multiple sclerosis patients. The results showed that the proportion of patients at high risk of COVID-19 mortality is below 1%, with the vast majority of these high-risk patients not receiving any disease-modifying treatment.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Review Virology

Impact of disease-modifying drugs on the severity of COVID-19 infection in multiple sclerosis patients

Sahar Rostami Mansoor et al.

Summary: Neurological manifestations can occur in severe cases of COVID-19, leading neurologists to pay special attention to patients with neurological disorders like MS. Administering proper DMTs is critical for MS patients during the pandemic as it can help reduce immune responses.

JOURNAL OF MEDICAL VIROLOGY (2021)

Review Health Care Sciences & Services

Impact of COVID-19 on people with physical disabilities: A rapid review

Audrey Lebrasseur et al.

Summary: The study aimed to review the impact of the COVID-19 pandemic on people with physical disabilities, finding that they faced challenges such as decreased access to healthcare, changes in social and lifestyle habits, mood changes, and decreased physical activity during the pandemic.

DISABILITY AND HEALTH JOURNAL (2021)

Article Health Policy & Services

Impact of the COVID-19 pandemic on persons with multiple sclerosis: Early findings from a survey on disruptions in care and self-reported outcomes

Tommaso Manacorda et al.

Summary: The COVID-19 pandemic in Italy caused disruptions in care for persons with Multiple Sclerosis, negatively impacting their health and wellbeing, especially their psychological health. Access to a broad range of health and care services is crucial for maintaining the wellbeing of these patients, and strategies should be in place to ensure continuity of care in future pandemic response plans.

JOURNAL OF HEALTH SERVICES RESEARCH & POLICY (2021)

Letter Clinical Neurology

Disability through COVID-19 pandemic: neurorehabilitation cannot wait

L. Leocani et al.

EUROPEAN JOURNAL OF NEUROLOGY (2020)

Article Clinical Neurology

COVID-19 outcomes in MS Observational study of early experience from NYU Multiple Sclerosis Comprehensive Care Center

Erica Parrotta et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)

Article Clinical Neurology

Multiple sclerosis management during the COVID-19 pandemic

Brandon P. Moss et al.

MULTIPLE SCLEROSIS JOURNAL (2020)

Article Clinical Neurology

Impact of the COVID-19 pandemic on the health care of >1,000 People living with multiple sclerosis: A cross-sectional study

Andre C. Vogel et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)

Article Public, Environmental & Occupational Health

Identifying Relapses in Multiple Sclerosis Patients through Administrative Data: A Validation Study in the Lazio Region, Italy

Paola Colais et al.

NEUROEPIDEMIOLOGY (2017)